Vanda Pharmaceuticals (VNDA) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.13
-0.07
-0.01
0.05

Details

Expected EPS
0.05
Actual EPS
-0.07
Surprise EPS
-0.12
Surprise Percent
+240%

Description

Vanda Pharmaceuticals (VNDA) has reported earnings of -0.07 per share for Q2 2024.

0 Comments

Share your thoughts